Trade Summary

6 days ago, Cole G Bradley, serving as Dir at Kiniksa Pharmaceuticals International, plc (KNSA), sold 3,673 shares at $81.43 per share, for a total transaction value of $299,092.39. Following this transaction, Cole G Bradley now holds 11,672 shares of KNSA.

This sale represents a 23.94% decrease in Cole G Bradley's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 29, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 31, 2026 at 4:34 PM ET, 2 days after the trade was made.

Kiniksa Pharmaceuticals International, plc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.